| Q35473306 | Assessment of symptoms of urinary incontinence in women with polycystic ovary syndrome |
| Q33762034 | Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome |
| Q38677404 | Do anabolic-androgenic steroids have performance-enhancing effects in female athletes? |
| Q44000443 | Inverse relationship between the changes in trunk lean and fat mass during gonadotropin-releasing hormone agonist therapy. |
| Q93081191 | Lean Women on Metformin and Oral Contraceptives for Polycystic Ovary Syndrome Demonstrate a Dehydrated Osteosarcopenic Phenotype: A Pilot Study |
| Q33904576 | MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. |
| Q44387533 | Pelvic floor muscle strength and urinary incontinence in hyperandrogenic women with polycystic ovary syndrome. |
| Q79166188 | Precedence of bone loss over changes in body composition and body fat distribution within a few years after menopause |
| Q74643980 | Relative contribution of aging and menopause to changes in lean and fat mass in segmental regions |
| Q53313477 | Surface electromyography and ultrasound evaluation of pelvic floor muscles in hyperandrogenic women. |